Press Release

Capillary Electrophoresis Market to Grow at CAGR of 5.92% through 2030

Demand for advanced analytical techniques in genomics & proteomics is expected to drive the Global Capillary Electrophoresis Market growth in the forecast period, 2026-2030.

 

According to TechSci Research report, “Capillary Electrophoresis Market – Global Industry Size, Share, Trends, Competition, Forecast & Opportunities, 2020-2030F”, the Global Capillary Electrophoresis Market stood at USD 385.23 Million in 2024 and is expected to reach USD 545.29 Million by 2030 with a CAGR of 5.92% during the forecast period.

The Global Capillary Electrophoresis Market is experiencing significant growth due to the increasing demand for precise, high-resolution analytical techniques across multiple industries, including biotechnology, pharmaceuticals, healthcare, and clinical diagnostics. Capillary electrophoresis (CE) is a versatile, efficient, and cost-effective analytical technique used for the separation and analysis of biomolecules, including proteins, nucleic acids, and small molecules. It offers a high degree of sensitivity, accuracy, and reproducibility, making it an essential tool for researchers and companies in drug development, clinical diagnostics, and molecular biology.

One of the key drivers of the Global Capillary Electrophoresis Market is the growing need for biologics and biosimilars, which require advanced analytical techniques for their development and quality control. As the demand for biologic therapies, such as monoclonal antibodies (mAbs) and gene therapies, continues to rise, the need for robust analytical solutions to characterize and purify these complex molecules has also increased. Capillary electrophoresis plays a critical role in the characterization of biologics by providing high-resolution separation, allowing for the analysis of protein purity, identity, and structure. This has driven the adoption of CE systems among pharmaceutical companies, as it helps them meet regulatory requirements and ensure the quality and safety of biologic drugs.

The growing emphasis on personalized medicine is contributing to the market’s expansion. Personalized medicine, which tailors treatments based on individual genetic and molecular profiles, requires sophisticated analytical techniques for identifying biomarkers, monitoring disease progression, and developing targeted therapies. CE is an invaluable tool in these areas, particularly in the analysis of genetic mutations, protein markers, and metabolic products. As the field of personalized medicine grows, demand for capillary electrophoresis is expected to increase, further driving the market.

In addition to biotechnology and pharmaceuticals, the Global Capillary Electrophoresis Market is also fueled by the increasing use of CE in clinical diagnostics. Clinical laboratories use capillary electrophoresis for various applications, such as genetic testing, cancer diagnostics, and hemoglobinopathies screening. CE offers the advantage of high precision and sensitivity in detecting disease markers, enabling early diagnosis and more accurate monitoring of conditions like genetic disorders, cancers, and autoimmune diseases. The growing prevalence of chronic diseases, such as cancer and genetic disorders, is thus driving the adoption of CE in clinical settings. CE’s ability to analyze multiple biomarkers simultaneously allows for more efficient and comprehensive diagnostic testing, further contributing to its widespread use.

Academic and research institutions also represent a significant portion of the Global Capillary Electrophoresis Market. These institutions rely on CE for fundamental research in areas such as genomics, proteomics, and drug discovery. CE is widely used in research settings for studying protein interactions, nucleic acid sequencing, and the analysis of metabolites. With the increasing focus on molecular research and the development of new therapies, academic and research institutions are adopting CE technologies for their high-throughput and high-resolution capabilities. The growing number of research projects related to cancer, genetic disorders, and infectious diseases is expected to boost the demand for CE systems in these settings.

The market is also benefiting from continuous advancements in capillary electrophoresis technology. Innovations in CE instruments, such as the integration of mass spectrometry (MS) for enhanced detection and the development of multi-capillary systems for higher throughput, have made CE more versatile and efficient. These technological improvements have expanded the range of applications for capillary electrophoresis, allowing it to be used for more complex analyses in a variety of industries. Automation and improved software solutions have made it easier to operate and interpret results from CE systems, increasing their appeal in both research and clinical environments.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Capillary Electrophoresis Market

 

The Global Capillary Electrophoresis Market is segmented into component, mode, application, end user, regional distribution, and company.

Based on mode, the Capillary Zone Electrophoresis (CZE) is currently the dominant method in the Global Capillary Electrophoresis Market. This dominance is largely due to CZE's widespread use, versatility, simplicity, and effectiveness in a wide array of applications, particularly in the pharmaceutical, biotechnology, and clinical diagnostics sectors. CZE is primarily used for the separation of charged particles based on their size-to-charge ratio, making it an essential tool for the analysis of proteins, nucleic acids, small molecules, and ions. The technique operates by applying an electric field to a capillary tube filled with a conductive buffer, causing the ions in the sample to migrate at different rates, thereby achieving separation. The primary advantage of CZE lies in its efficiency and speed. It provides high-resolution separation with minimal sample consumption, which is crucial for industries that deal with limited sample volumes, such as clinical diagnostics and research applications. The ability of CZE to separate complex mixtures with high precision makes it particularly popular for applications in drug development, quality control, and molecular biology. In the pharmaceutical and biotechnology industries, CZE is widely used to analyze the purity, stability, and structure of biologic drugs and biosimilars, as well as to monitor the quality of small molecule pharmaceuticals. CZE plays a pivotal role in the analysis of genetic material, such as DNA and RNA, which is crucial for drug discovery, diagnostics, and personalized medicine.

CZE's simplicity and cost-effectiveness also make it an attractive option for many laboratories and research institutions. The technique does not require complex sample preparation or expensive reagents, making it easier to adopt, especially in environments with budget constraints. CZE systems are generally more compact and require less maintenance compared to other electrophoresis-based methods, such as Capillary Electro Chromatography (CEC). These factors contribute to CZE’s widespread use and market dominance. In contrast, Capillary Electro Chromatography (CEC), while an emerging technique, holds a smaller market share compared to CZE. CEC is a hybrid technique that combines the principles of capillary electrophoresis with liquid chromatography, offering additional capabilities for separating complex mixtures. CEC allows for the separation of compounds based on both their charge and their interaction with a stationary phase inside the capillary, making it suitable for applications requiring higher resolution and more complex separations. While CEC offers advantages such as improved selectivity for certain types of compounds, its complexity, higher cost, and requirement for more sophisticated equipment have limited its widespread adoption compared to CZE.

Based on region, Europe is the second-largest market, following North America in terms of market share and growth. Europe has a well-established healthcare infrastructure, strong pharmaceutical and biotechnology sectors, and a growing emphasis on research and development (R&D), all of which contribute to its significant position in the capillary electrophoresis (CE) market. European countries like Germany, the United Kingdom, Switzerland, and France are key players in the market due to their advanced scientific research capabilities, high investment in biotechnology, and strong presence of academic and clinical laboratories that extensively use CE for various applications.

One of the major drivers of the capillary electrophoresis market in Europe is the region's focus on biologics and biosimilars. With Europe being home to several global pharmaceutical companies, the demand for CE systems in the analysis of biologics is substantial. CE plays a vital role in the characterization and quality control of biologic drugs such as monoclonal antibodies (mAbs) and vaccines. The European Medicines Agency (EMA) sets rigorous regulatory standards for biologics, making the use of high-precision analytical techniques like capillary electrophoresis critical to ensure that pharmaceutical products meet safety, purity, and potency requirements. The growing emphasis on biosimilars—biologic products that are similar to an already-approved reference biologic—also contributes to the increased use of CE in the region, as manufacturers need reliable technologies to verify the structural integrity and purity of these products. Europe has a strong academic and research presence, with numerous prestigious universities, research institutes, and laboratories that rely on capillary electrophoresis for scientific discovery. The growing focus on genomics, proteomics, and molecular biology has further expanded the applications of CE in research, driving market growth in the region. As research institutions increasingly focus on personalized medicine, cancer therapies, and rare disease diagnostics, the demand for high-resolution, reliable separation techniques like CE continues to rise.

 

Major companies operating in Global Capillary Electrophoresis Market are:

  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc
  • Merck KGaA
  • Promega Corporation
  • Shimadzu Corporation
  • LABGENE Scientific SA


Download Free Sample Report

Customers can also request for 10% free customization on this report

 

The Global Capillary Electrophoresis Market is poised for significant growth in the coming years, driven by increasing demand for high-resolution analytical techniques in pharmaceuticals, biotechnology, clinical diagnostics, and academic research. The growing adoption of biologics, biosimilars, and personalized medicine is expected to boost the need for precise separation methods in drug development and quality control. Advancements in capillary electrophoresis technology, such as improved automation, integration with mass spectrometry, and the development of multi-capillary systems, will enhance efficiency and broaden its application across industries. The rising focus on genomics, proteomics, and disease diagnostics will further fuel market expansion. With continuous innovation and increased adoption in emerging markets, the capillary electrophoresis market is set for robust growth, providing opportunities for key stakeholders globally.,” said Mr. Karan Chechi, Research Director, TechSci Research, a research-based management consulting firm.

Capillary Electrophoresis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Instruments, Consumables, Software), By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others), By Application (Nucleic Acid Analysis and Protein Analysis), By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Capillary Electrophoresis Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Capillary Electrophoresis Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com

Relevant News